Touko Asano et al. revealed that the amount of CD169+ macrophages significantly correlated with the abundance of CD8+ cells and the favorable survival in bladder cancer, suggesting that CD169+ macrophages may play an anti-tumor role by boosting cytotoxic T-cell-mediated anti-tumor immunity [18]. The gene discussed is SIGLEC1; the disease is urinary bladder carcinoma.